Chamomile (Matricaria chamomilla): Sleep, Anxiety & GI Health — A Research-Backed Guide
⚡ 60-Second Summary
Chamomile (Matricaria chamomilla, also written Matricaria recutita) is one of the most thoroughly studied medicinal herbs in Western tradition, with credible human RCT evidence for anxiety, sleep quality, and GI complaints. Its three primary bioactive groups — apigenin (flavone, partial GABA-A agonist), alpha-bisabolol (sesquiterpene alcohol, anti-inflammatory), and alpha-chamazulene (formed during steam distillation, anti-inflammatory, responsible for the characteristic blue essential oil colour) — each contribute to different effects.
Sleep and anxiety: The Zick 2011 RCT (200 mg/day) and the Amsterdam 2016 long-term RCT (1500 mg/day, 26 weeks for generalised anxiety disorder) are the anchor studies. Effects are genuine but modest — chamomile is useful as a first-line option for mild-to-moderate anxiety and sleep issues, not a replacement for CBT-I or prescription anxiolytics in severe cases.
GI use: Well-established anti-spasmodic and anti-inflammatory effects on GI smooth muscle make chamomile a useful adjunct for IBS and functional dyspepsia.
Key cautions: Warfarin interaction (via CYP2C9 inhibition); cross-reactivity with ragweed and other Asteraceae plants. Do not use near surgery with anticoagulant medications.
Typical dose: 200–500 mg standardised extract (1.2% apigenin) 1–2x daily; or 2–3 cups of strong chamomile tea per day.
What is chamomile?
Chamomile refers most commonly to German chamomile (Matricaria chamomilla / Matricaria recutita) — a daisy-like annual flowering plant in the Asteraceae family, native to Europe and Western Asia but now cultivated worldwide. Roman chamomile (Chamaemelum nobile) is a related but distinct species with somewhat different phytochemistry; most clinical research and modern standardised extracts use German chamomile.
The flower heads — both fresh and dried — are the medicinal portion. Chamomile essential oil (a dark blue liquid due to chamazulene) is used topically and in aromatherapy. Commercially, chamomile is available as whole dried flowers (for tea), standardised capsule extracts (most commonly standardised to apigenin percentage), and as an ingredient in topical creams and ointments.
Chamomile is among the top-10 most widely consumed herbal teas worldwide, with particular prevalence in Germany, where it is approved by Commission E for GI upset, skin inflammation, and as an oral rinse.
Active compounds and mechanisms
| Compound | Compound class | Primary mechanism | Best-supported effect |
|---|---|---|---|
| Apigenin | Flavone | Partial agonist at GABA-A benzodiazepine receptor sites; CYP enzyme modulation | Anxiolytic and sedative effects; accounts for warfarin interaction |
| Alpha-bisabolol | Sesquiterpene alcohol | Inhibits 5-LOX and COX; mucosal protection; anti-spasmodic | GI inflammation and wound healing; topical anti-inflammatory |
| Alpha-chamazulene | Sesquiterpene (essential oil) | COX-1 and COX-2 inhibition; antioxidant | Topical anti-inflammatory; the blue colour of chamomile oil |
| Luteolin, quercetin | Flavonoids | NF-kB inhibition; mast cell stabilisation | General anti-inflammatory; anti-allergy |
| Herniarin, umbelliferone | Coumarins | Antispasmodic; mild anticoagulant potential | GI smooth muscle relaxation; contributes to warfarin interaction risk |
Sleep and anxiety: what the RCTs show
Zick et al. 2011 — the sleep trial
This 28-day RCT (n=34 chronic insomniacs) comparing 200 mg of chamomile extract twice daily versus placebo found significant improvements in sleep diary scores, including reduced nighttime awakening and better reported sleep quality. Objective sleep measures (actigraphy) showed trends in the same direction but did not reach statistical significance, suggesting chamomile's sleep benefits are subjectively meaningful even if not as large as pharmaceutical hypnotics. This study remains the anchor reference for chamomile sleep claims.
Amsterdam et al. 2009 and 2016 — anxiety trials
The 2009 pilot RCT (n=57, 8 weeks, 220–1100 mg/day standardised chamomile extract) showed significant reductions in Hamilton Anxiety Rating Scale (HAM-A) scores versus placebo. The landmark 2016 long-term trial (n=179, 26 weeks) was the first to test chamomile for relapse prevention in remitted generalised anxiety disorder. At 1500 mg/day (500 mg three times daily), chamomile significantly delayed relapse compared to placebo during a 26-week follow-up phase. This is meaningful evidence that chamomile has genuine anxiolytic activity, not just a sedating placebo effect.
Elderly and postpartum populations
A 2017 RCT in elderly nursing home residents (n=60, 400 mg/day, 4 weeks) showed improved sleep quality scores. A 2016 RCT in postnatal women found improved sleep quality and reduced depression scores versus control with regular chamomile tea consumption. These populations appear particularly responsive.
GI anti-spasmodic and anti-inflammatory effects
The German Commission E approved chamomile for GI spasms and inflammatory GI conditions in 1994, based on a substantial body of in vitro, animal, and clinical evidence. The primary GI mechanisms are:
- Smooth muscle anti-spasm: Alpha-bisabolol and apigenin relax GI smooth muscle, reducing cramping and colic. This is the basis for chamomile's traditional use in infant colic (though evidence in infants is from older, lower-quality trials).
- Mucosal protection: Alpha-bisabolol reduces gastric acid secretion and promotes gastric mucus production, protecting against ulcer formation in animal models.
- Anti-inflammatory: Chamazulene and bisabolol reduce local inflammatory cytokines in the gut wall, supported by in vitro and some clinical evidence for IBS and functional dyspepsia.
A systematic review of 9 studies on chamomile for functional GI disorders found consistent directional benefit, though most trials were small and methodologically heterogeneous.
Topical anti-inflammatory use
Chamomile extract is a well-documented topical anti-inflammatory. In a double-blind RCT, a chamomile cream was superior to hydrocortisone 0.25% cream for eczema and dermatitis — though hydrocortisone 0.5% remained more effective. Chamomile is commonly used in wound-care creams and ointments for minor skin inflammation, abrasions, and insect bite reactions. Patch test for Asteraceae allergy is appropriate before topical use in allergy-prone individuals.
Dosage: tea vs standardised extract
| Form | Typical dose | Apigenin content (approximate) | Best for |
|---|---|---|---|
| Chamomile tea (infusion) | 1–3 cups/day (1–3 g dried flowers per cup) | ~0.5–2 mg apigenin per cup (variable) | Mild GI complaints, mild sleep/anxiety support, daily ritual |
| Standardised extract capsule (1.2% apigenin) | 200–500 mg 1–3x daily | 2.4–6 mg apigenin per 200 mg dose | Sleep (Zick RCT dose), mild anxiety, consistency of dosing |
| High-dose extract for anxiety (as per Amsterdam RCT) | 500 mg 3x daily (1500 mg total) | ~18 mg apigenin/day | Generalised anxiety disorder — discuss with clinician before this dose |
| Essential oil (topical) | Apply diluted 1–3% in carrier oil | High chamazulene and bisabolol | Topical anti-inflammatory, skin irritation, aromatherapy |
Safety, allergy, and the ragweed problem
Asteraceae cross-reactivity (ragweed allergy)
Chamomile belongs to the Asteraceae family, which is botanically related to ragweed (Ambrosia species), chrysanthemum, feverfew, echinacea, and daisy. Shared allergens — including sesquiterpene lactones — can cause cross-reactive allergic reactions in individuals sensitised to ragweed pollen or any Asteraceae plant. Reactions range from oral allergy syndrome and contact dermatitis to rhinitis and, in rare reported cases, anaphylaxis. People with known ragweed, chrysanthemum, or Asteraceae allergy should be assessed by an allergist before using chamomile internally or topically.
General safety
- At typical doses (up to 1500 mg/day), chamomile extract has an excellent safety record in clinical trials up to 26 weeks
- Mild sedation at higher doses — do not drive or operate machinery within 2 hours of a large dose
- Avoid high-dose supplemental chamomile in pregnancy (emmenagogue properties at very high doses in animal studies); culinary tea amounts are generally considered safe
- Topical use may cause allergic contact dermatitis in Asteraceae-sensitised individuals — patch test first
Drug interactions — warfarin and beyond
| Drug | Interaction mechanism | Clinical significance |
|---|---|---|
| Warfarin | Apigenin inhibits CYP2C9 (primary warfarin-S metabolism enzyme), raising warfarin levels; coumarin content may have additive anticoagulant effect | HIGH — documented case reports of over-anticoagulation. INR monitoring required. Inform prescriber before use. |
| CNS depressants (benzodiazepines, alcohol, sleep medications) | Additive sedative effect via GABA-A receptor modulation | MODERATE — avoid concurrent use; may cause excess sedation |
| CYP2C9 substrate drugs (phenytoin, celecoxib, some SSRIs) | Apigenin inhibits CYP2C9, potentially raising blood levels | MODERATE — discuss with prescriber if taking drugs with narrow therapeutic windows |
| Cyclosporine | Apigenin may inhibit P-glycoprotein efflux and CYP3A4, raising cyclosporine levels | MODERATE — avoid in organ transplant patients without specialist guidance |
Check our free interaction checker for additional combinations.
Frequently asked questions
Does chamomile actually help with sleep?
Yes — with moderate evidence. The Zick 2011 RCT at 200 mg/day showed improved sleep quality scores in chronic insomniacs. The mechanism is via apigenin binding GABA-A benzodiazepine sites. Effects are genuine but modest; chamomile works better as a first-line option for mild sleep issues than as an alternative to prescription hypnotics.
Does chamomile interact with warfarin?
Yes — this is a clinically documented interaction with case reports. Apigenin inhibits CYP2C9, raising warfarin levels and bleeding risk. Anyone on warfarin should not regularly consume chamomile tea or supplements without their prescriber's knowledge and INR monitoring.
Can I take chamomile if I have a ragweed allergy?
Use caution — cross-reactivity between chamomile and ragweed is documented. Reactions range from mild to severe (including rare anaphylaxis). Consult an allergist before using chamomile if you have a ragweed or Asteraceae allergy.
What dose of chamomile is effective for anxiety?
The Amsterdam 2016 RCT used 1500 mg/day (500 mg three times daily) for GAD. Lower doses of 200–500 mg/day have shown benefits for mild anxiety and sleep. Tea provides more variable apigenin concentrations than standardised capsules.
Is chamomile safe during pregnancy?
Culinary amounts (1–2 cups of tea per day) are generally considered safe. High-dose supplemental chamomile extract is not recommended during pregnancy due to emmenagogue potential at very high doses in animal studies. Consult your midwife or OB.
Related ingredients and articles
Valerian Root
The other major herbal sleep supplement — GABAergic mechanism compared to chamomile.
Passionflower
Another GABA-A modulating herb for anxiety — mechanism and evidence overview.
Natural Sleep Supplements Ranked
How chamomile compares to melatonin, ashwagandha, and L-theanine.
Herbal Anxiety Supplements: What Works
Chamomile, ashwagandha, lavender, and kava — evidence compared.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.